Evonik Venture Capital has invested in a 3D-printing start-up in China that makes implants for neuro and spine surgery.
The technology enables faster recovery and fewer post-operation checks for patients and less surgical risk for doctors.
Evonik is the lead investor in a high single-digit million-euro round of fundraising for Shanghai-based Meditool.